Fulcrum Therapeutics, Inc. (FULC)
USD 2.92
(8.55%)
USD 2.92
(8.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.8 Million | 6.34 Million | 19.16 Million | 8.82 Million | - | - |
| Cost of Revenue | 71.8 Million | 2.41 Million | 2.51 Million | 2.37 Million | 2.05 Million | 1.34 Million |
| Gross Profit | -68.99 Million | 3.92 Million | 16.64 Million | 6.44 Million | -2.05 Million | -1.34 Million |
| Operating Expenses | 113.46 Million | 118.47 Million | 100.21 Million | 80.43 Million | 84.21 Million | 33.49 Million |
| Selling, General and Administrative Expenses | 41.66 Million | 41.69 Million | 30.51 Million | 21.39 Million | 13.14 Million | 8.31 Million |
| Research and Development Expenses | 71.8 Million | 76.78 Million | 69.7 Million | 59.04 Million | 71.07 Million | 25.18 Million |
| Other Expenses | - | 2.69 Million | 207 Thousand | 792 Thousand | 29 Thousand | 392 Thousand |
| Cost and Expenses | 113.46 Million | 118.47 Million | 100.21 Million | 80.43 Million | 84.21 Million | 33.49 Million |
| Operating Income | -110.66 Million | -112.56 Million | -81.05 Million | -71.61 Million | -84.21 Million | -33.49 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -4.25 Million | -2.51 Million | -2.37 Million | -3.56 Million | 910 Thousand |
| Earnings before Tax | -97.33 Million | -109.87 Million | -80.84 Million | -70.81 Million | -82.67 Million | -32.58 Million |
| Net Income | -97.33 Million | -105.62 Million | -78.33 Million | -68.44 Million | -79.11 Million | -32.58 Million |
| Earnings Per Share Basic | -1.59 | -2.35 | -2.22 | -2.70 | -7.16 | -1.92 |
| Earnings Per Share Diluted | -1.59 | -2.35 | -2.22 | -2.70 | -7.16 | -1.92 |
| Weighted Average Shares Outstanding | 61.31 Million | 44.99 Million | 35.36 Million | 25.35 Million | 11.04 Million | 16.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 61.31 Million | 44.99 Million | 35.36 Million | 25.35 Million | 11.04 Million | 16.94 Million |
| Gross Margin | -24.60 | 0.62 | 0.87 | 0.73 | - | - |
| EBIT Margin | -38.68 | -17.61 | -4.23 | -8.12 | - | - |
| Profit Margin | -34.70 | -16.65 | -4.09 | -7.76 | - | - |
| EBITDA | -108.49 Million | -109.72 Million | -78.53 Million | -69.23 Million | -82.16 Million | -32.15 Million |
| Earnings Before Tax Margin | -39.45 | -17.75 | -4.23 | -8.12 | - | - |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 FY | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 80 Million | - | 871 Thousand | 2.8 Million | 759 Thousand | 880 Thousand |
| Cost of Revenue | 400 Thousand | 479 Thousand | 508 Thousand | 2.17 Million | 500 Thousand | 600 Thousand |
| Gross Profit | 79.6 Million | -479 Thousand | 363 Thousand | 633 Thousand | 259 Thousand | 280 Thousand |
| Operating Expenses | 27.1 Million | 29.35 Million | 28.35 Million | 111.29 Million | 28.19 Million | 28.17 Million |
| Selling, General and Administrative Expenses | 10.24 Million | 10.06 Million | 9.35 Million | - | 9.96 Million | 10.32 Million |
| Research and Development Expenses | 16.86 Million | 19.29 Million | 18.99 Million | - | 18.23 Million | 17.84 Million |
| Other Expenses | 2.91 Million | 2.96 Million | 3.23 Million | 13.32 Million | 3.42 Million | 3.5 Million |
| Cost and Expenses | 27.5 Million | 29.83 Million | 28.86 Million | 113.46 Million | 28.19 Million | 28.17 Million |
| Operating Income | 52.49 Million | -29.83 Million | -27.99 Million | -110.66 Million | -27.44 Million | -27.29 Million |
| Interest Expense | - | - | 3.16 Million | - | - | - |
| Income Tax Expense | - | 435.18 Thousand | 3.16 Million | 2 Million | 408.91 Thousand | 525.41 Thousand |
| Earnings before Tax | 55.4 Million | -26.87 Million | -24.75 Million | -97.33 Million | -24.01 Million | -23.78 Million |
| Net Income | 55.4 Million | -26.87 Million | -24.75 Million | -97.33 Million | -24.01 Million | -23.78 Million |
| Earnings Per Share Basic | 0.89 | -0.43 | -0.40 | - | -0.39 | -0.38 |
| Earnings Per Share Diluted | 0.87 | -0.43 | -0.40 | - | -0.39 | -0.38 |
| Weighted Average Shares Outstanding | 62.2 Million | 61.98 Million | 61.87 Million | 61.31 Million | 61.82 Million | 61.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 63.58 Million | 61.98 Million | 61.87 Million | 61.31 Million | 61.82 Million | 61.79 Million |
| Gross Margin | 1.00 | - | 0.42 | 0.23 | 0.34 | 0.32 |
| EBIT Margin | 0.66 | - | -31.55 | - | -35.45 | -30.37 |
| Profit Margin | 0.69 | - | -28.42 | -34.70 | -31.64 | -27.03 |
| EBITDA | 52.89 Million | -29.35 Million | -27.48 Million | - | -26.9 Million | -26.72 Million |
| Earnings Before Tax Margin | 0.66 | - | -32.14 | -39.45 | -36.15 | -31.01 |
SN
4167
CORT
2181
E25
CDW